Omeros Stock - Shares hold above 200-day line after recent rally
18.06.2026 - 14:31:42 | ad-hoc-news.de
Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 14:30 CET. Details in the imprint.
Omeros Corp (US6821431029) is back on traders' screens as the biotech name trades firmly above a rising 200-day moving average on the Nasdaq. With no new filings or press releases in the past day, Thursday's lens is squarely on the stock's technical setup.
Background and real-time data on Omeros stock
All recent news, filings and price data on Omeros stock can be found in the dedicated topic section and via the company’s investor-relations pages.
What recent prices show
According to the company’s own stock quote page, Omeros shares last closed at $9.33 on 06/15/2026, up 6.8% on the day, with intraday trading between $8.82 and $9.61 and volume just under 2.0 million shares. The IR stock-quote section lists Nasdaq as the primary venue.
That close leaves the stock well above many third-party estimates of its recent 200-day moving average, with MarketBeat data also flagging a cross above that long-term trend line after a prolonged period below it. MarketBeat’s Omeros news page recently highlighted the move above the 200-day mark.
Thursday focus on the chart
From a technical standpoint, the 200-day moving average often acts as a dividing line between longer-term downtrends and more constructive phases. Omeros now trades above that level, which technicians view as a sign of improving medium-term momentum.
Shorter-term dynamics are more nuanced. After the sharp gain into mid-June, traders will watch whether Omeros can consolidate without giving back too much ground, or whether profit-taking pulls the shares back toward their recent breakout zone around the moving average.
The product behind the stock
Omeros generates its revenue primarily from Omidria, an ophthalmic drug used during cataract surgery to maintain pupil dilation and reduce postoperative eye pain, alongside a broader pipeline of complement-targeting candidates in immunology and oncology.
Where the stock trades today
The shares of Omeros Corp (US6821431029) trade on the Nasdaq at $9.33 as of 06/15/2026, 16:00 ET.
Key facts on Omeros stock
- Company: Omeros Corp.
- ISIN: US6821431029
- WKN: A1JRUU
- Ticker: OMER
- Venue: Nasdaq
- Price (as of 06/15/2026, 16:00 ET): 9.33 USD
- Market cap: 0.0 USD (as of 06/15/2026)
- Sector / Industry: Health Care / Biotechnology
- Index membership: none of the major blue-chip indices
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
